thanks for the summary! different colour??? WOW!Just watched the Davis video.
Highlights:
1. Seeing genetic differences, including in locations related to infection (kur locus (spelling?)). sample size only 20 though so doing a validation study in 2018.
2. Finding no pathogens. In fact fewer viruses than in controls. Continuing to look though, using new technology.
3. Detail on the sample size for the imepdance assay: 11 patients, 10 controls. So far all patients show the unique signal (decrease then increase in impedance), and none of the controls. They are getting more controls in.
4. findings in blood flow. They're finding different characteristics in patient blood: it's "strange, a little sticky", "a little different in colour" (!!!) and flows differently through artificial capillaries. And they are developing technology to measure this.
[seriously if our blood is a different colour that's the easiest biomarker I ever heard of. A person with a pair of scissors and a few paint swatches could diagnose anyone!)
5. working eventually toward not only distinguishing patients from controls but also from other ilnesses like MS, Lyme etc.